Axcan beats Street

Gastrointestinal company Axcan (TSX:AXP; AXCA) reported diluted GAAP EPS of $0.19 for the first quarter of fiscal 2006, beating the Street estimate by $0.04 and up 19% from $0.16 in the same period la...